미국의 상처 세척 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 제품 형태별, 용도별, 최종 용도별, 부문별 예측(2025-2030년)

U.S. Wound Wash Market Growth & Trends:

The U.S. wound wash market size is anticipated to reach USD 420.81 million by 2030 and is anticipated to expand at a CAGR of 5.56% during the forecast period, according to a new report by Grand View Research, Inc. The U.S. wound wash market is experiencing significant growth due to the increasing number of surgical procedures, trauma cases, and the rising prevalence of chronic wounds such as diabetic ulcers and pressure sores. Traditional wound cleansing methods have evolved with advancements in antimicrobial agents, biofilm-disrupting solutions, and automated irrigation systems, making wound care more effective and efficient. The shift toward advanced antimicrobial solutions is one of the most essential factors driving the wound wash market.

New product launches and FDA approvals in the U.S. wound wash market drive significant wound and surgical wash advancements by promoting innovation, enhancing safety standards, and improving clinical outcomes. In June 2023, VeriCyn Wound Wash from Armis Biopharma obtained 510(k) clearance from the FDA, marking a significant advancement in wound care solutions. This regulatory approval enhances the credibility and adoption of the product, ensuring it meets safety and efficacy standards for wound debris removal. The approval also reflects ongoing technological advancements in wound and surgical washes, promoting the development of innovative, antimicrobial, and bioactive formulations. As demand for safe and effective wound cleansing solutions grows, such FDA approvals drive market expansion, improve patient outcomes, and encourage further innovations in the U.S. wound wash market.

Furthermore, the U.S. wound care market is significantly influenced by increased investments from military sectors and industry players through strategic collaborations and partnerships. These factors collectively drive innovation, enhance product development, and expand market reach, propelling growth. For instance, in January 2024, the U.S. Army has awarded Minnesota's 3M Company a USD 34.2-million contract to develop medical solutions for traumatic wounds, infection, and associated healing processes. These initiatives aim to enhance care for acute trauma cases such as blasts, burns, and gunshot wounds in military and civilian settings.

U.S. Wound Wash Market Report Highlights:

• Based on product, the antiseptic segment dominate the market with the largest revenue share owing to their effectiveness in preventing infection, a primary concern in wound care.
• Based on product form, the solutions segment dominate the market with the largest revenue share owing to their versatility, ease of use, and ability to clean a wide range of wounds.
• Based on application, the acute wound segment dominate the market with the largest revenue share. Acute wounds, being more common and often requiring immediate care, drive the demand for wound wash products.
• Based on end-use, the hospitals dominated the market with the largest revenue share owing to their high volume of patients and diverse wound care needs. Hospitals are the largest consumers of wound wash products.

Table of Content

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
• 1.4. Information or Data Analysis
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Wound Wash Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing number of surgical procedures
    • 3.2.1.2. Rising prevalence of chronic wounds
    • 3.2.1.3. Advancements in wound and surgical washes
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Stringent regulatory approvals & compliance costs
    • 3.2.2.2. Adverse events and complications associated with the use of wound wash
• 3.3. U.S. Wound Wash Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's Five Forces
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. U.S. Wound Wash Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Wound Wash Market Product Movement Analysis
• 4.3. U.S. Wound Wash Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Antiseptic
  • 4.4.1. Antiseptic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.2. Povidone Iodine
    • 4.4.2.1. Povidone Iodine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.3. Chlorhexidine
    • 4.4.3.1. Chlorhexidine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.4. Polyhexanide (PHMB)
    • 4.4.4.1. Polyhexanide (PHMB) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.5. Others
    • 4.4.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Saline Solution
  • 4.5.1. Saline Solution Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Irrigation Solution
  • 4.6.1. Irrigation Solution Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.7. Pulsed Lavage Systems
  • 4.7.1. Pulsed Lavage Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7.2. Disposable
    • 4.7.2.1. Disposable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7.3. Reusable
    • 4.7.3.1. Reusable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7.4. Semi Disposable
    • 4.7.4.1. Semi Disposable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.8. Others
  • 4.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. Wound Wash Market: Product Form Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. Wound Wash Market Product Form Movement Analysis
• 5.3. U.S. Wound Wash Market Size & Trend Analysis, by Product Form, 2018 to 2030 (USD Million)
• 5.4. Solutions
  • 5.4.1. Solutions Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Sprays
  • 5.5.1. Sprays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Wipes
  • 5.6.1. Wipes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Others
  • 5.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. U.S. Wound Wash Market: Application Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. U.S. Wound Wash Market Application Movement Analysis
• 6.3. U.S. Wound Wash Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 6.4. Acute Wounds
  • 6.4.1. Acute Wounds Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.2. Surgical & Traumatic Wounds
    • 6.4.2.1. Surgical & Traumatic Wounds Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.3. Burns & Lacerations
    • 6.4.3.1. Burns & Lacerations Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Chronic Wounds
  • 6.5.1. Chronic Wounds Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.2. Diabetic Foot Ulcers
    • 6.5.2.1. Diabetic Foot Ulcers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.3. Pressure Ulcers
    • 6.5.3.1. Pressure Ulcers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.4. Venous Leg Ulcers
    • 6.5.4.1. Venous Leg Ulcers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.5. Other Chronic Wounds
    • 6.5.5.1. Other Chronic Wounds Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. U.S. Wound Wash Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. U.S. Wound Wash Market End Use Movement Analysis
• 7.3. U.S. Wound Wash Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 7.4. Hospitals
  • 7.4.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.5. Specialty Clinics
  • 7.5.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Ambulatory Surgery Centers
  • 7.6.1. Ambulatory Surgery Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.7. Military & Defense
  • 7.7.1. Military & Defense Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.8. Others
  • 7.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Key Company Profiles
  • 8.2.1. Atlantis Consumer Healthcare Inc.
    • 8.2.1.1. Company Overview
    • 8.2.1.2. Financial Performance
    • 8.2.1.3. Service Benchmarking
    • 8.2.1.4. Strategic Initiatives
  • 8.2.2. Medline Industries, LP
    • 8.2.2.1. Company Overview
    • 8.2.2.2. Financial Performance
    • 8.2.2.3. Service Benchmarking
    • 8.2.2.4. Strategic Initiatives
  • 8.2.3. B. Braun SE
    • 8.2.3.1. Company Overview
    • 8.2.3.2. Financial Performance
    • 8.2.3.3. Service Benchmarking
    • 8.2.3.4. Strategic Initiatives
  • 8.2.4. Johnson & Johnson Consumer Inc. (Johnson & Johnson)
    • 8.2.4.1. Company Overview
    • 8.2.4.2. Financial Performance
    • 8.2.4.3. Service Benchmarking
    • 8.2.4.4. Strategic Initiatives
  • 8.2.5. Zimmer Biomet
    • 8.2.5.1. Company Overview
    • 8.2.5.2. Financial Performance
    • 8.2.5.3. Service Benchmarking
    • 8.2.5.4. Strategic Initiatives
  • 8.2.6. Urgo Medical North America (URGO Group)
    • 8.2.6.1. Company Overview
    • 8.2.6.2. Financial Performance
    • 8.2.6.3. Service Benchmarking
    • 8.2.6.4. Strategic Initiatives
  • 8.2.7. Coloplast Corp (Coloplast Group)
    • 8.2.7.1. Company Overview
    • 8.2.7.2. Financial Performance
    • 8.2.7.3. Service Benchmarking
    • 8.2.7.4. Strategic Initiatives
  • 8.2.8. Molnlycke Health Care AB
    • 8.2.8.1. Company Overview
    • 8.2.8.2. Financial Performance
    • 8.2.8.3. Service Benchmarking
    • 8.2.8.4. Strategic Initiatives
  • 8.2.9. Cardinal Health
    • 8.2.9.1. Company Overview
    • 8.2.9.2. Financial Performance
    • 8.2.9.3. Service Benchmarking
    • 8.2.9.4. Strategic Initiatives
  • 8.2.10. Armis Biopharma
    • 8.2.10.1. Company Overview
    • 8.2.10.2. Financial Performance
    • 8.2.10.3. Service Benchmarking
    • 8.2.10.4. Strategic Initiatives
  • 8.2.11. Bravida Medical
    • 8.2.11.1. Company Overview
    • 8.2.11.2. Financial Performance
    • 8.2.11.3. Service Benchmarking
    • 8.2.11.4. Strategic Initiatives
  • 8.2.12. Irrimax Corporation
    • 8.2.12.1. Company Overview
    • 8.2.12.2. Financial Performance
    • 8.2.12.3. Service Benchmarking
    • 8.2.12.4. Strategic Initiatives
  • 8.2.13. BD
    • 8.2.13.1. Company Overview
    • 8.2.13.2. Financial Performance
    • 8.2.13.3. Service Benchmarking
    • 8.2.13.4. Strategic Initiatives
  • 8.2.14. Sanara MedTech Inc.
    • 8.2.14.1. Company Overview
    • 8.2.14.2. Financial Performance
    • 8.2.14.3. Service Benchmarking
    • 8.2.14.4. Strategic Initiatives
  • 8.2.15. Pure&Clean
    • 8.2.15.1. Company Overview
    • 8.2.15.2. Financial Performance
    • 8.2.15.3. Service Benchmarking
    • 8.2.15.4. Strategic Initiatives
  • 8.2.16. Innovacyn, Inc.
    • 8.2.16.1. Company Overview
    • 8.2.16.2. Financial Performance
    • 8.2.16.3. Service Benchmarking
    • 8.2.16.4. Strategic Initiatives